US Patent Issued to The Eye Hospital of Wenzhou Medical University, Wenzhou Oja Biotechnology on Sept. 22 for "Protection sequence, primer, probe, composition and kit for steady-state rapid detection of novel coronavirus, and use thereof and method therefor" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,213, issued on Sept. 22, was assigned to The Eye Hospital of Wenzhou Medical University (Wenzhou City, China) and Wenzhou Oja Biotechnology Co. Ltd. (Wenzhou City, China).

"Protection sequence, primer, probe, composition and kit for steady-state rapid detection of novel coronavirus, and use thereof and method therefor" was invented by Tao Xu (Wenzhou City, China), Jingu Wang (Wenzhou City, China), Jiangfan Chen (Wenzhou City, China) and Jia Qu (Wenzhou City, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention uses a lysis protection solution to treat patient samples, and the samples release genes targeting the 2019-nCOV virus...